Scope:
Keywords:
Update

News about Abbvie.Ie

28 days ago

Analyse the news about Abbvie.Ie from multiple sources, get visualizations or extract the entire dataset.

Related dashboards:

Healthy Returns: AbbVie is the newest potential weight loss drug market player

Read on: CNBC News link
28d ago

Beyond the Possible: How AbbVie Uses Technology to Transform Medicines for Patients

Read on: CBS link
49d ago

Stocks making the biggest moves midday: AbbVie, Tesla, Cigna, Morgan Stanley and more

Read on: CNBC News link
146d ago

Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors

Read on: CNBC News link
342d ago

AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez

Read on: CNBC News link
412d ago

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

Read on: CNBC News link
494d ago

Drugmaker AbbVie to spend over $10 billion on ImmunoGen to juice its cancer-fighting treatment portfolio

Read on: Chicago Tribune link
494d ago

Dataset

Extract all news on this scope:

Analysis

See the trend on this scope:

Evolution through time

Sources analysis:

Distribution of sources in the news

Sections analysis:

Distribution of sections in the news

Current sentiment polarity: neutral with a score of 0.03

neutral 71%
negative 14%
positive 14%

Sentiment polarity through time